Beyond Regulatory Requirements: Maximising the Value of Toxicology Studies to De-Risk Preclinical Development

2:15 pm - Wednesday 2nd December 2026

  • Understanding the critical role of toxicology studies in supporting safe and successful radiopharmaceutical development
  • Exploring how developers can generate additional translational insights from toxicology programmes beyond minimum regulatory requirements
  • Examining the unique considerations associated with designing and interpreting toxicology studies for radiopharmaceuticals

Speakers:

CEO
Nuclide Therapeutics